What is peripheral arterial tonometry?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Peripheral Arterial Tonometry?

Peripheral arterial tonometry (PAT) is a non-invasive plethysmographic technique that measures pulsatile volume changes in the digital arteries of the fingertip using a probe that applies uniform pressure around the entire digit, primarily used to assess sympathetic nervous system activity, vascular function, and arterial stiffness.

Technical Mechanism

PAT technology works by applying a uniform pressure field (near diastolic blood pressure levels) that completely envelopes the distal finger, including its tip 1. This pressure optimization:

  • Maximizes the dynamic range of the pulse signal
  • Prevents confounding veno-arteriolar reflex vasoconstriction at the measurement site
  • Reduces respiratory and movement artifacts
  • Facilitates accurate long-term measurement 1

The fingertip vascular bed is a major site of sympathetic nervous system-mediated vasoconstrictor activity, making it an ideal location for detecting autonomic changes 1.

Clinical Applications

Arterial Stiffness Assessment

PAT is one of several tonometry-based techniques used to measure pulse wave velocity (PWV) for assessing arterial stiffness 2. Tonometry-based devices use piezoelectric transducers placed at pulse-detectable sites to record pressure waveforms, with measurements typically ECG-gated to calculate transit times between arterial segments 2.

Common tonometry devices include SphygmoCor, Complior, and PulsePen, which have demonstrated good reproducibility in measuring carotid-femoral PWV—the gold standard for arterial stiffness assessment 2, 3.

Sleep Apnea Detection

PAT has been extensively validated for ambulatory sleep apnea diagnosis through devices like Watch-PAT 4, 5, 1. The technology detects:

  • Apneas and hypopneas with high correlation to polysomnography (r = 0.89) 4, 5
  • Autonomic arousals with strong correlation (r = 0.77) 4
  • Sympathetic activation associated with respiratory events 6

PAT identifies 92% of respiratory events compared to only 35% detected by visual EEG arousals, demonstrating its high sensitivity to autonomic changes 7. However, because arousals are not specific to sleep apnea, PAT's specificity is limited for diagnostic purposes in children 7.

Vascular Function Assessment

PAT measures two distinct vascular parameters:

  1. Baseline pulse amplitude: Reflects basal blood flow and arterial pressure pulsatility 8, 9
  2. PAT ratio (Reactive Hyperemia Index): Calculated as the post-to-pre occlusion pulse signal ratio during reactive hyperemia, corrected for baseline vascular tone 9

The baseline digital pulse amplitude correlates strongly with brachial artery blood flow velocity (r = 0.63-0.64) but does NOT correlate with flow-mediated dilation or reactive hyperemia-induced changes 8. This indicates PAT primarily reflects basal hemodynamics rather than endothelial-dependent vasodilation.

Clinical Outcomes Data

In the Framingham Heart Study (n=3,865), higher PAT ratio during reactive hyperemia was associated with:

  • 24% lower risk of incident stroke (HR 0.76, p=0.013) 9
  • 32% lower risk of ischemic stroke specifically (HR 0.68, p=0.001) 9
  • No significant association with composite CVD events or myocardial infarction 9

In critically ill patients, PAT measurements correlate with disease severity and mortality:

  • Lower baseline PAT values predict early mortality (each 0.1 decrease in ln(RHI) increases mortality odds by 13%) 10
  • PAT improvement over 7 days predicts survival (survivors: +63.9% vs. non-survivors: -24.2%, p=0.026) 10
  • Lower PAT correlates with renal and cardiovascular dysfunction 10

Important Caveats

  • PAT cannot substitute for direct blood pressure measurement but provides complementary information on sympathetic and parasympathetic tone 6
  • The reactive hyperemia PAT ratio does not reflect traditional flow-mediated dilation measured by brachial ultrasound 8
  • In pediatric populations, PAT cannot replace EEG-based arousal scoring due to limited specificity, though it detects autonomic arousals not visible on EEG 7
  • PAT is most useful for therapy monitoring in established sleep apnea patients rather than initial diagnosis 4, 5

References

Research

Peripheral arterial tonometry-PAT technology.

Sleep medicine reviews, 2022

Guideline

how to measure arterial stiffness in humans.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2020

Research

Ambulatory recording of sleep apnea using peripheral arterial tonometry.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 2004

Research

Peripheral arterial tonometry for the diagnosis of obstructive sleep apnea.

Biomedizinische Technik. Biomedical engineering, 2002

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
For an adult with occasional constipation, how do Dulcolax (bisacodyl) and Senna (sennosides) compare regarding efficacy, dosing, onset of action, and safety?
What are the eligibility criteria for Dupilumab (Dupixent) and other eosinophil‑targeting biologics in patients with chronic allergic diseases?
In a 19-year-old female with painless cervical lymphadenopathy, should lactate dehydrogenase (LDH) be checked?
In a 19‑year‑old female with painless cervical lymphadenopathy, does an LDH (lactate dehydrogenase) level of 167 U/L suggest high tumor burden or aggressive lymphoma?
Should clonazepam be used for restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), and what is the recommended initiation and monitoring protocol?
What is the appropriate treatment for a patient with a six‑month history of scrotal tenderness and ultrasound findings consistent with epididymitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.